PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Gastroenterology, Royal Devon and Exeter NHS Foundation Trust, Exeter, UK.\', \'Exeter Inflammatory Bowel Disease and Pharmacogenetics Research Group, University of Exeter, Exeter, UK.\', \'Department of Biochemistry, Exeter Clinical Laboratory International, Royal Devon and Exeter NHS Foundation Trust, Exeter, UK.\', \'Department of Gastroenterology, Shrewsbury and Telford Hospital NHS Trust, Shrewsbury, UK.\', \'Department of Gastroenterology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.\', \'Department of Paediatric Gastroenterology, Royal London Hospital, Barts Health NHS Trust, London, UK.\', \'Centre for Immunobiology, Blizard Institute, Barts and the London School of Medicine, Queen Mary University of London, London, UK.\', \'Department of Gastroenterology, St Mark\'s Hospital and Academic Institute, Harrow, London, UK.\', \'Department of Gastroenterology, Guy\'s and St Thomas\' NHS Foundation Trust, London, UK.\', \'School of Immunology & Microbial Sciences, King\'s College London, London, UK.\', \'Department of Gastroenterology, Royal London Hospital, Barts Health NHS Trust, London, UK.\', \'Department of Gastroenterology, Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle Upon Tyne, UK.\', \'Translational & Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK.\', \'Department of Gastroenterology, Pennine Acute Hospitals NHS Trust, Manchester, UK.\', \'Faculty of Biology, Medicine & Health, University of Manchester, Manchester, UK.\', \'Department of Gastroenterology, Queen Elizabeth University Hospital, NHS Greater Glasgow and Clyde, Glasgow, UK.\', \'F. Widjaja Foundation Inflammatory Bowel and Immunology Research Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA.\', \'Department of Gastroenterology, University College London Hospitals NHS Foundation Trust, London, UK.\', \'Department of Gastroenterology, Royal Free London NHS Foundation Trust, London, UK.\', \'Department of Gastroenterology, St George\'s University Hospitals NHS Foundation Trust, London, UK.\', \'Institute for Infection and Immunity, University of London, London, UK.\', \'Department of Gastroenterology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.\', \'Department of Paediatric Gastroenterology, Royal Hospital for Sick Children, NHS Lothian, Edinburgh, UK.\', \'Department of Gastroenterology, Leeds Teaching Hospitals NHS Trust, Leeds, UK.\', \'Department of Gastroenterology, Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK.\', \'Medical School, University of Exeter, Exeter, UK.\', \'Department of Gastroenterology, Western General Hospital, NHS Lothian, Edinburgh, UK.\', \'Institute of Genetic and Molecular Medicine, University of Edinburgh, Edinburgh, UK.\', \'Department of Gastroenterology, Hull University Teaching Hospitals NHS Trust, Hull, UK.\', \'Division of Digestive Diseases, Faculty of Medicine, Imperial College London, London, UK.\', \'Department of Metabolism, Digestion and Reproduction, Imperial College London, London, UK.\', \'Department of Gastroenterology, Royal Devon and Exeter NHS Foundation Trust, Exeter, UK tariq.ahmad1@nhs.net.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1136/gutjnl-2021-324388
?:doi
?:hasPublicationType
?:journal
  • Gut
is ?:pmid of
?:pmid
?:pmid
  • 33753421
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 7.44
?:rankingScore_hIndex
  • 251
?:title
  • Anti-SARS-CoV-2 antibody responses are attenuated in patients with IBD treated with infliximab.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all